Author:
Saleh Tareq Abdullah,Al-Harbi Hussein Jasim,Dwayyikh Abbas Thamer,Abdullah Shaymaa Obiad
Reference28 articles.
1. N. Mohammed, S. M. Sudha, and P.S. Dattatreya. Serum free light chain ratio in correlation with serum protein electrophoresis in myeloma patients from south India. Int J Pharm Bio Sci; 6(1): (B) 1074 – 1080 (2015).
2. R. Butova, P. Vychytilova-Faltejskova, A. Souckova, S. Sevcikova, and R. Hajek. Long Non-Coding RNAs in Multiple Myeloma. Non-coding RNA; 5(13) : 1–15(2019).
3. T. C. Michels, and K.E. Petersen. Multiple Myeloma: Diagnosis and Treatment. Am Fam Physician; 95(6):373–383 (2017).
4. PROGNOSTIC VALUE OF THE BONE TURNOVER MARKERS IN MULTIPLE MYELOMA
5. E. Terpos, I. Ntanasis-Stathopoulos, M. Gavriatopoulou, and M.A. Dimopoulos. Pathogenesis of bone disease in multiple myeloma: from bench to bedside Evangelos. Blood Cancer Journal; 8:7 : 1–12 (2018).